Adv. Sci. 2021, 8, 2100014
In the originally published article, the representative BLI images of treated mice in Figure 6D present the wrong samples (the third in the second row, and the third in the fourth row). The correct Figure 6D is shown below. The authors declare that this correction does not affect the description, interpretation, or the original conclusions of the manuscript. The authors regret the inconvenience this error may have caused.
Figure 6.
Targeting KAT6A sensitizes PD‐L1 immunotherapy in TNBC by decreasing MDSCs recruitment. D) Representative BLI images of treated mice on Day 21.